Analyst picks & changes

Biogen Inc.

(BGEN)

Raymond James analyst C. Anthony Butler said data presented at the AHA meeting on BGEN's

Hirulog

showed the drug to be

Read the full 258 word article

How to gain access

Continue reading with a
two-week free trial.